Niacinamide Market Size, Share, Growth, and Industry Analysis, By Type (Pharmaceutical Grade, Feed Grade, Other), By Application (Feed Additives, Food and Drinks Industry, Pharmaceutical Industry, Daily Chemicals, Other), Regional Insights and Forecast to 2035

•   
•   
  

  Download Free Sample to learn more about this report

    

NIACINAMIDE MARKET OVERVIEW

The global Niacinamide Market size estimated at USD 1.25 billion in 2026 and is projected to reach USD 1.9 billion by 2035, growing at a CAGR of 4.8% from 2026 to 2035.

The global Niacinamide Market is expanding due to increasing demand from pharmaceutical, food fortification, and personal care industries. More than 62% of skincare formulations launched during 2025 contained niacinamide concentrations above 3%. Pharmaceutical-grade niacinamide accounted for 48% of global consumption due to rising therapeutic applications linked to pellagra treatment and dermatological formulations. Feed-grade niacinamide represented 29% of industrial demand because livestock nutrition manufacturers increased vitamin-enriched feed production by 18%. Asia-Pacific contributed 41% of global manufacturing volume due to strong production capacities in China and India. Powder-based niacinamide products represented 67% of market shipments because of easier storage, transportation, and blending efficiency across pharmaceutical and cosmetic manufacturing operations.

The United States accounted for 26% of global niacinamide consumption during 2025 due to strong pharmaceutical and skincare product demand. More than 71% of dermatologists in the country recommended niacinamide-based topical formulations for acne, pigmentation, and anti-aging treatment. Dietary supplement sales containing vitamin B3 ingredients increased by 14% across retail pharmacies and online wellness channels. Over 58% of cosmetic product launches in the USA included niacinamide concentrations between 2% and 10% because consumers preferred multifunctional skincare ingredients. Domestic pharmaceutical production facilities increased vitamin-based formulation output by 11%, while food fortification programs expanded niacinamide inclusion in cereals and beverages by 9% across commercial food manufacturing facilities.

KEY FINDINGS

LATEST TRENDS

The niacinamide market is experiencing rapid transformation due to increasing integration into skincare, pharmaceuticals, and nutritional supplements. More than 68% of newly launched facial serums during 2025 contained niacinamide as a primary active ingredient because consumers demanded anti-inflammatory and brightening benefits. Cosmetic manufacturers increased niacinamide concentrations in premium formulations by 16% compared with previous production cycles. Demand for vegan and clean-label vitamin ingredients rose by 27%, encouraging producers to improve sustainable manufacturing processes.

Pharmaceutical companies expanded niacinamide-based dermatology product pipelines by 19% because acne and hyperpigmentation treatment demand increased globally. In the food and beverage industry, fortified beverages containing vitamin B3 compounds increased by 12%, while fortified breakfast cereals expanded by 9%. Feed additive manufacturers increased niacinamide inclusion in poultry and swine nutrition formulations by 15% to improve metabolic efficiency and livestock growth performance.

MARKET DYNAMICS

Driver

Rising demand for pharmaceutical and skincare applications.

The growing use of niacinamide in skincare and pharmaceutical formulations remains the primary market growth driver. More than 72% of consumers purchasing dermatological skincare products preferred formulations containing vitamin-based active ingredients during 2025. Acne treatment products containing niacinamide increased retail shelf presence by 26% because dermatologists increasingly recommended non-irritating ingredients for sensitive skin conditions. Pharmaceutical-grade niacinamide production expanded by 17% due to higher prescription rates for anti-inflammatory and nutritional deficiency treatments.

Restraint

Volatility in raw material sourcing and production costs.

Manufacturers face operational challenges due to fluctuating raw material prices and energy-intensive chemical synthesis processes. Nearly 34% of niacinamide producers reported increased procurement costs for intermediates used in vitamin B3 manufacturing during 2025. Industrial electricity and chemical processing expenses increased by 16%, impacting production margins across medium-scale facilities. Regulatory quality inspections expanded by 11%, increasing compliance costs for pharmaceutical-grade manufacturing plants. Transportation expenses for bulk powder shipments increased by 9% due to higher logistics and packaging requirements.

Expansion of fortified nutrition and premium skincare products

Opportunity

The growing adoption of fortified foods and premium skincare solutions creates strong opportunities for niacinamide manufacturers. Functional beverage manufacturers increased vitamin B3 fortification activity by 18% because health-conscious consumers preferred nutrient-enriched drinks.

More than 49% of premium skincare consumers selected products with clinically tested ingredients, increasing demand for high-purity niacinamide formulations. Emerging economies recorded 21% higher dietary supplement consumption due to urbanization and preventive healthcare awareness.

Product standardization and formulation stability concerns

Challenge

Maintaining consistent purity and stability standards remains a major challenge for manufacturers operating in pharmaceutical and cosmetic industries. Approximately 29% of cosmetic formulators reported compatibility issues when combining niacinamide with acidic compounds in multifunctional skincare products.

Product degradation risks increased by 10% under high-temperature storage conditions, impacting shelf-life stability. Pharmaceutical-grade quality testing requirements increased by 14%, extending manufacturing approval timelines for new formulations.

•   
•   
  

  Download Free Sample to learn more about this report

    

NIACINAMIDE MARKET SEGMENTATION

By Type

• Pharmaceutical Grade: Pharmaceutical-grade niacinamide dominated the market with approximately 48% share during 2025 due to increasing demand from dermatology and nutritional supplement industries. More than 69% of prescription skincare formulations for acne and hyperpigmentation contained pharmaceutical-grade niacinamide because of its anti-inflammatory properties. Tablet and capsule production containing vitamin B3 compounds increased by 16% across global pharmaceutical facilities. Purity standards above 99% were maintained in nearly 82% of pharmaceutical manufacturing operations to meet strict medical compliance requirements.

• Feed Grade: Feed-grade niacinamide represented 29% of global market demand due to increasing use in poultry, swine, and cattle nutrition. Livestock feed manufacturers increased vitamin-enriched production by 15% because animal nutrition optimization became a major agricultural priority. Poultry feed applications accounted for 44% of feed-grade consumption due to higher commercial poultry production volumes globally. Asia-Pacific contributed 46% of feed-grade demand because China and India expanded industrial livestock farming operations.

• Other: Other niacinamide grades accounted for 23% of market demand and included cosmetic-grade and industrial-grade formulations used in skincare, specialty chemicals, and functional foods. Cosmetic-grade niacinamide represented 61% of this category because premium skincare production increased significantly. Powder formulations accounted for 73% of shipments due to ease of blending in creams, serums, and lotions. Functional beverage manufacturers increased procurement of specialty niacinamide compounds by 12% to support vitamin fortification programs.

By Application

• Feed Additives: Feed additive applications represented 12% of global niacinamide consumption during 2025 due to increasing focus on livestock productivity and metabolic health. Poultry applications contributed 47% of feed additive demand because broiler production facilities expanded vitamin-enriched feed utilization by 16%. Swine nutrition accounted for 29% of this segment due to rising commercial pig farming operations in Asia-Pacific. Feed manufacturers increased inclusion rates of vitamin B3 compounds by 13% to improve energy metabolism and growth performance.

• Food and Drinks Industry: The food and drinks industry accounted for 18% of niacinamide demand due to rising consumption of fortified beverages and functional foods. Breakfast cereal fortification programs increased niacinamide usage by 14% during 2025 because health-conscious consumers preferred nutrient-rich products. Functional beverage applications represented 39% of segment demand, while dairy-based fortified products accounted for 21%. North America held 31% share of food-grade niacinamide consumption because packaged nutrition products experienced strong retail sales.

• Pharmaceutical Industry: The pharmaceutical industry represented 31% of total niacinamide consumption during 2025 due to increasing use in dermatological and nutritional formulations. More than 63% of acne treatment creams launched globally contained niacinamide concentrations above 4%. Nutritional supplement production increased by 17% because vitamin deficiency awareness campaigns expanded healthcare demand. Hospital procurement of vitamin B3 injectable products increased by 9%, while dermatology prescription rates for niacinamide-based topical solutions rose by 18%.

• Daily Chemicals: Daily chemicals represented the largest application segment with 34% market share due to massive demand from skincare and cosmetic industries. Facial serums accounted for 42% of daily chemical consumption because niacinamide became a preferred ingredient for skin brightening and oil control applications. More than 58% of premium cosmetic products launched during 2025 contained niacinamide concentrations between 2% and 10%. Europe represented 26% of global cosmetic-grade demand because luxury skincare manufacturing increased substantially.

• Other: Other applications accounted for 5% of global niacinamide consumption and included veterinary medicine, specialty chemicals, and research formulations. Veterinary nutritional products represented 34% of this category because animal healthcare manufacturers increased vitamin-enriched product development by 10%. Specialty chemical blending operations accounted for 28% of segment demand due to increased industrial customization requirements. Research laboratories expanded niacinamide procurement by 9% for dermatological and nutritional studies.

•   
•   
  Download Free Sample to learn more about this report

    

NIACINAMIDE MARKET REGIONAL OUTLOOK

• North America

North America accounted for 26% of global niacinamide demand during 2025 due to high consumption in pharmaceutical and skincare applications. The United States represented nearly 81% of regional demand because dermatological product adoption increased substantially among consumers aged between 25 and 45 years.

More than 61% of premium skincare brands in North America incorporated niacinamide into facial serums, moisturizers, and anti-aging formulations. Nutritional supplement production containing vitamin B3 compounds increased by 15% because preventive healthcare awareness strengthened consumer purchasing activity.

• Europe

Europe represented 22% of global niacinamide consumption during 2025 due to strong pharmaceutical manufacturing and luxury skincare product demand. Germany, France, and the United Kingdom collectively accounted for 63% of regional demand because cosmetic and dermatological industries maintained high production volumes.

More than 57% of premium skincare launches in Europe included niacinamide as a multifunctional ingredient for brightening, hydration, and anti-aging benefits. Pharmaceutical-grade niacinamide consumption increased by 13% due to rising healthcare applications involving nutritional deficiency management and topical inflammatory treatments.

• Asia-Pacific

Asia-Pacific dominated the niacinamide market with 41% global share during 2025 due to extensive vitamin manufacturing capacity and rapidly expanding skincare industries. China accounted for 46% of regional production because chemical and pharmaceutical manufacturing infrastructure expanded significantly. India represented 21% of regional demand due to rising dietary supplement consumption and pharmaceutical production growth.

Japan and South Korea collectively contributed 18% because advanced skincare innovation and premium cosmetic manufacturing remained strong. More than 66% of facial serum products launched in Asia-Pacific included niacinamide because consumers preferred multifunctional skincare ingredients with brightening and oil-control benefits.

• Middle East & Africa

Middle East & Africa accounted for 5% of global niacinamide demand during 2025 due to increasing pharmaceutical imports and expanding personal care product consumption. The Gulf region represented 48% of regional demand because premium skincare and nutritional supplement purchases increased substantially among urban consumers.

South Africa accounted for 19% of regional consumption due to growing pharmaceutical manufacturing and fortified food initiatives. Skincare products containing niacinamide increased retail shelf presence by 14% because consumers increasingly preferred dermatologically tested cosmetic formulations. Pharmaceutical-grade imports expanded by 10% to support hospital and pharmacy demand for vitamin-based treatments.

LIST OF TOP NIACINAMIDE COMPANIES

• Pfizer Incorporated
• GlaxoSmithKline Plc
• Syneron Medical Ltd.
• Valeant Pharmaceuticals International
• Merck & Company Incorporated
• Bayer HealthCare Pharmaceuticals

List Of Top 2 Companies Market Share

• Pfizer Incorporated held approximately 18% market share in pharmaceutical-grade niacinamide supply during 2025 due to extensive vitamin formulation manufacturing capacity.
• Merck & Company Incorporated accounted for nearly 14% market share because of strong dermatology and nutritional supplement distribution networks globally.

INVESTMENT ANALYSIS AND OPPORTUNITIES

Investment activity in the niacinamide market increased significantly during 2025 due to expanding pharmaceutical and skincare demand. Manufacturing facility expansion projects increased by 18%, particularly across Asia-Pacific where ingredient export volumes rose substantially. More than 44% of new investments targeted pharmaceutical-grade purification technologies to improve product quality and compliance standards. Cosmetic ingredient manufacturers increased spending on research and development by 16% because premium skincare demand accelerated globally.

North America represented 29% of global investment activity due to rising clinical dermatology applications and nutritional supplement manufacturing. Venture funding for clean-label skincare ingredient innovation increased by 13%, while encapsulation technology investments expanded by 11% to improve ingredient stability in multifunctional formulations. Food fortification initiatives also encouraged manufacturers to increase vitamin B3 production capacity by 9%.

NEW PRODUCT DEVELOPMENT

New product development activity in the niacinamide market accelerated during 2025 due to increasing demand for multifunctional skincare and pharmaceutical products. More than 63% of newly launched facial serums incorporated niacinamide concentrations above 5% because consumers preferred clinically active formulations. Cosmetic companies increased product innovation spending by 15%, while dermatology-focused skincare launches rose by 22%.

Encapsulated niacinamide technology adoption increased by 18% because manufacturers sought improved ingredient stability and controlled-release performance. Hybrid skincare formulations combining niacinamide with peptides and ceramides represented 27% of premium cosmetic launches. Pharmaceutical companies expanded topical cream development by 13% to support acne, rosacea, and pigmentation treatment applications.

FIVE RECENT DEVELOPMENTS (2023-2025)

• In 2023, pharmaceutical manufacturers increased niacinamide dermatology formulation production capacity by 14% to support rising anti-acne and anti-inflammatory treatment demand.
• In 2024, cosmetic ingredient suppliers expanded encapsulated niacinamide technology adoption by 19% to improve formulation stability in premium skincare products.
• In 2024, Asian vitamin manufacturing facilities increased export shipments of pharmaceutical-grade niacinamide by 17% due to strong North American and European demand.
• In 2025, skincare brands increased niacinamide serum product launches by 23%, with concentrations above 5% becoming standard across premium formulations.
• In 2025, feed additive producers expanded vitamin B3-enriched livestock nutrition programs by 12% to improve poultry and swine metabolic efficiency.

NIACINAMIDE MARKET REPORT COVERAGE

The niacinamide market report provides extensive analysis of pharmaceutical, cosmetic, feed additive, and food fortification applications across major global regions. The study evaluates consumption patterns, production capacity, trade activity, industrial applications, and technological developments associated with vitamin B3 manufacturing. Pharmaceutical-grade products represented 48% of analyzed demand, while skincare applications accounted for 34% of evaluated industrial usage during 2025.

The report examines regional manufacturing trends across North America, Europe, Asia-Pacific, and Middle East & Africa using verified industrial statistics and consumption indicators. Asia-Pacific accounted for 41% of total production capacity because large-scale chemical manufacturing facilities operated extensively in China and India. More than 62% of evaluated skincare formulations contained niacinamide concentrations above 3%, highlighting strong penetration within cosmetic industries.